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Lactate dehydrogenase (LDH) catalyses the conversion of pyruvate to lactate,
utilizing NADH as co-factor. It’s a tetrameric enzyme composed of two subunits, M and
H, whose association can generate five isoforms. One of this, the human isoform 5,
hLDH5  has  the  highest  activity  in  converting  pyruvate  to  lactate  under  anaerobic
conditions, such as those found in hypoxic tumors and for this reason it’s up-regulated
in tumor tissues where cells glycolytic rate is up to 200 times higher than that of the
normal tissue.  hLDH5 inhibition should cause cancer cell death by starvation, without
interfering  with  healthy  cells  that  normally  use  oxidative  phosphorylation  for  ATP
generation  (1).  Inhibition  of  LDH is  so  considered  as  a  promising  target  in  cancer
treatment, and natural compounds could serve as useful scaffold to study new anticancer
agents. Among the few plant derived  hLDH5 inhibitors already investigated there are
mainly phenolic derivatives such as gossypol, morin, and galloflavin (2,3).
In  the  last  decade  our  research  group  successfully  detected  a  good  number  of
compounds  obtained  from Mediterranean  plants  with  anticancer  effect,  and  for  this
reason  start  a  research  program aimed  to  discover  new classes  of  natural  products
having  hLDH5 inhibitory  activity.  In  a  first  study,  since  some  species  of  Phlomis
(Lamiaceae) proved to possess anti-cancer properties, the crude extract of  P. kurdica
aerial  parts  was selected  as the starting material.  Two new flavonoids  and one new
phenylpropanoid,  together  with  eleven  known  phenolic  compounds,  including
flavonoids and phenylpropanoids were isolated and assayed for their hLDH5 inhibitory
activity.  Luteolin  7-O-β-d-glucopyranoside  showed  an  IC50  value  similar  to  that of 
reference compound galloflavin (4). Then, since Polygala genus (Polygalaceae) is well
known  to  contain  phenolic  oligosaccharides,  xanthones,  lignans,  and  triterpenic
saponins and it’s largely used in the traditional medicine, an Italian species P. flavescens
subsp.  flavescens was chosen. Ten new compounds were isolated from the methanol
residue of the aerial parts through Sephadex and RP-HPLC separations, including four
flavonol  glycosides,  two  oligosaccharides,  one  α-ionone,  and  three  triterpenoidic
saponins, together with two known oligosaccharides and two flavonol glycosides. The
isolates  were  assayed  for  their  inhibitory  activity  against  hLDH5  and  3,6'-di-O-
sinapoylsucrose showed an inhibition potency comparable or even slightly better than
reference  inhibitor  galloflavin.  Docking studies  were  carried  out  to  hypothesize  the
interaction mode of active compounds in the enzyme active site.
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